GLP-1s seen as key to managing T1D with obesity
The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in addition to insulin is increasingly being viewed as a method for addressing the rising
The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in addition to insulin is increasingly being viewed as a method for addressing the rising
Recent research has found that insufficient sleep duration and late sleep onset were associated with increased glycaemic variability in middle-aged and older adults. Suboptimal sleep,
Obesity must be recognized and treated as a disease. This was the central message of the 23rd European Congress of Internal Medicine (ECIM), held recently.
Researchers at Imperial College, London are recruiting adults with Type 1 diabetes to a study aimed at better understanding the impact day-to-day stigma can have
ViCentra B.V., the company behind Kaleido, the insulin patch pump and automated insulin delivery (AID) system, has announced the appointment of Tom Arnold as Chief
Being a lab rat or a guinea pig does not sound all that attractive, at least to most of us. However, at the same time
ViCentra has announced that its Kaleido insulin pump has received CE certification under the EU Medical Device Regulation. The Kaleido pump includes two durable pumps,
Leicester Diabetes Centre (LDC), Loughborough University and UK logistics company, Wincanton have announced that their health promotion programme, the ‘Structured Health Intervention for Truckers’ (SHIFT),
Technology has come a long way since the first blood glucose meter was developed in 1965. Now, diabetes patients have access to continuous glucose monitors
The first phase of the roll-out of hybrid closed loop systems to NHS integrated care systems continues. Following a successful pilot by NHS England, in